Tags: Cancer Drugs | Stocks | Merck | Bristol

Shares of Merck, Bristol Rise on Cancer Drug News

Monday, 03 Jun 2013 01:36 PM

Shares of Bristol-Myers Squibb Inc. and Merck & Co. both rose more than 3 percent Monday after the drugmakers announced encouraging results on experimental cancer medicines over the weekend.

Both companies' drugs for advanced cases of melanoma are in a new class that helps the patient's immune system identify and destroy tumor cells that otherwise would evade detection.

And both drugs are part of a promising new area of cancer research called immuno-oncology in which drugs rev up the patient's immune system to fight their cancer, rather than killing cancer and healthy cells, as chemotherapy does.

Industry analysts say such drugs could become the new standard for treating many cancer types.

Bristol-Myers shares rose 3.4 percent to end at $47.59, while Merck shares were up 3.8 percent at $48.45.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
InvestingAnalysis
Shares of Bristol-Myers Squibb Inc. and Merck Co. both rose more than 3 percent Monday after the drugmakers announced encouraging results on experimental cancer medicines over the weekend.
Cancer Drugs,Stocks,Merck,Bristol
129
2013-36-03
Monday, 03 Jun 2013 01:36 PM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved